Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial - Concepedia

Concepedia

Publication | Open Access

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

DOI Full Paper Access

481

Citations

30

References

2004

Year

Henry Q. Xiong, Arthur Rosenberg, Albert F. LoBuglio, William Schmidt, Robert A. Wolff, John C. Deutsch, Michael N. Needle, James L. Abbruzzese

Journal of Clinical Oncology

Abstract

Cetuximab in combination with gemcitabine showed promising activity against advanced pancreatic cancer. Further clinical investigation is warranted.

References

	Year	Citations

Page 1